Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sagamore Bioventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$24M
Portfolio companies 3
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Exits 2
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Medical
  • Medical Device
  • Health Care
  • Biotechnology
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sagamore Bioventures:
Typical Co-investors
Sagamore Bioventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sagamore Bioventures:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Carleton Advisors Cleveland, Ohio, United States
Dingli Communications China, Guangdong, Zhuhai
Global Grand Capital -
IBG Risikokapitalfonds II GmbH & Co. KG -
Jiankun Investment Beijing, Beijing, China
Jisu Ziben China, Hangzhou, Zhejiang
Kehui Venture Capital China, Shanghai
Kelly Gamma -
Lotus Venture Capital Chaoyang, China, Liaoning
M31 Italia Srl Italy, Padova, Veneto
Maxima Capital Management Taipei, Taiwan
Quantum Leaps Corporation Chiyoda, Japan
Rezayat Investments England, London, United Kingdom
Smart Lenders Asset Management Ltd England, London, United Kingdom
SVG Media Gurgaon, Haryana, India
Tarsadia Investments California, Newport Beach, United States
TMT Connekt Dubai, United Arab Emirates
Triton Funds LLC California, Los Angeles, United States
Verso Capital Belgium, Luxembourg, Luxembourg

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ASLAN Pharmaceuticals

Biotechnology
Medical
Pharmaceutical
$34M07 Dec 2015 Singapore, Central Region, Singapore

ASLAN Pharmaceuticals

Biotechnology
Medical
Pharmaceutical
$22M10 Oct 2013 Singapore, Central Region, Singapore

TransMedics

Health Care
Medical
Medical Device
$29M14 Mar 2006 Massachusetts, United States

Presidio Pharmaceuticals

Biotechnology
Drug Discovery
Medical
Other Pharmaceuticals and Biotechnology
Pharmaceutical
Pharmaceuticals
01 Mar 2006 San Francisco, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sagamore Bioventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 24M
Peak activity year 2006
Lead investments 0
Follow on index 0.50
Exits 2
Group Appearance index 0.83

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

ASLAN Pharmaceuticals

Biotechnology
Medical
Pharmaceutical
$34M07 Dec 2015 Singapore, Central Region, Singapore

ASLAN Pharmaceuticals

Biotechnology
Medical
Pharmaceutical
$22M10 Oct 2013 Singapore, Central Region, Singapore

TransMedics

Health Care
Medical
Medical Device
$29M14 Mar 2006 Massachusetts, United States

Presidio Pharmaceuticals

Biotechnology
Drug Discovery
Medical
Other Pharmaceuticals and Biotechnology
Pharmaceutical
Pharmaceuticals
01 Mar 2006 San Francisco, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: